Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:CVBF
NasdaqGS:CVBFBanks

How Earnings Gains and a 3% Buyback At CVB Financial (CVBF) Have Changed Its Investment Story

CVB Financial Corp. previously reported fourth-quarter 2025 net interest income of US$122.66 million and net income of US$55.04 million, with full-year 2025 figures rising to US$460.29 million and US$209.30 million, respectively. Alongside this earnings growth, the company completed a share repurchase of 4,321,777 shares for US$80.40 million, reducing its share count by just over 3% and signaling management’s confidence in the business. Next, we’ll examine how CVB Financial’s earnings...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity (RVTY) One Off US$92.7m Loss Challenges Bullish Earnings Narratives

Revvity (RVTY) closed out FY 2025 with Q4 revenue of US$772.1 million and basic EPS of US$0.85, compared with Q4 FY 2024 revenue of US$729.4 million and EPS of US$0.73. Trailing 12 month figures show revenue of US$2.9 billion and EPS of US$2.06. Over the past year, quarterly revenue has moved from US$664.8 million in Q1 2025 to US$772.1 million in Q4 2025, while EPS has ranged between US$0.35 and US$0.85. With margins under pressure in the trailing period and expectations anchored to higher...
NYSE:ZGN
NYSE:ZGNLuxury

Is Ermenegildo Zegna (ZGN) Pricing Reflecting Its Listed Luxury Group Growth Story?

If you are wondering whether Ermenegildo Zegna shares offer good value at today’s price, you are not alone. This article is designed to walk you through what the market might be pricing in. The stock last closed at US$9.00, with recent returns showing a 6.2% decline over 7 days, a 13.7% decline over 30 days and year to date, and a 3.4% gain over 1 year. This gives a mixed picture of how sentiment and perceived risk have shifted over different time frames. Recent news coverage has focused on...
NasdaqGM:WINA
NasdaqGM:WINASpecialty Retail

Should Winmark’s (WINA) S&P Index Additions and Dividend Hike Require Action From Investors?

Winmark Corporation announced that its Board of Directors approved a quarterly cash dividend of US$0.96 per share, payable on March 2, 2026 to shareholders of record as of February 11, 2026, while also being added in January 2026 to the S&P 600, S&P 1000, S&P Composite 1500 and the S&P 600 Consumer Discretionary index. The combination of new S&P index inclusions and a continued quarterly dividend program highlights Winmark’s growing presence among institutional investors and income-focused...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Is Clearway Energy (CWEN.A) Pricing Look Interesting After 45.8% One Year Share Gain?

If you are wondering whether Clearway Energy's current share price offers good value, this article walks through what the numbers are saying about the stock today. Over the last year, Clearway Energy's share price is up 45.8%, with a 4.0% return over the past month and a 1.1% decline over the last week. These moves may have changed how the market views its risk and opportunity. Recently, investors have been reacting to broader clean energy sentiment and company specific updates on its...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Is It Time To Reconsider ACADIA Pharmaceuticals (ACAD) After Strong One Year Share Price Gain?

If you are trying to figure out whether ACADIA Pharmaceuticals is priced attractively right now, you are in the right place. The stock recently closed at US$26.13, with returns of 41.2% over 1 year, 31.6% over 3 years and a 49.0% decline over 5 years. Shorter term moves of 2.7% over 7 days and 0.6% over 30 days show a quieter near term picture. Recent news around ACADIA has focused on its position within the pharmaceuticals and biotech space and investor interest in how its product pipeline...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Sanmina’s AI Infrastructure Growth Meets Valuation Questions For Investors

Sanmina (NasdaqGS:SANM) reports strong top line growth in its latest quarter, supported by demand for next generation AI infrastructure and network systems. Revenue is supported by communications networks and cloud infrastructure, with initial shipments of next generation AI products contributing to performance. Management highlights ZT Systems as a key upcoming growth driver, alongside additional momentum in industrial and medical markets. Sanmina, an electronics manufacturing services and...
ENXTAM:VLK
ENXTAM:VLKCapital Markets

Assessing Van Lanschot Kempen’s (ENXTAM:VLK) Valuation After Winning Holcim Pension Mandate

Van Lanschot Kempen (ENXTAM:VLK) has been appointed to manage £2.5b in assets for two Holcim pension schemes, a win that underscores its institutional fiduciary offering and highlights additional recurring fee potential. See our latest analysis for Van Lanschot Kempen. The Holcim pension win lands at a time when Van Lanschot Kempen’s share price has eased back, with a 30 day share price return of a 3.76% decline and a year to date share price return of a 3.76% decline. However, the 1 year...
NYSE:PB
NYSE:PBBanks

Prosperity Bancshares Merger Expands Texas Reach But Raises Execution Questions

Prosperity Bancshares (NYSE:PB) has completed its merger with Southwest Bancshares and its subsidiary, Texas Partners Bank. The combination expands Prosperity Bancshares' regional presence across Texas and Oklahoma. Leadership from Texas Partners Bank is joining the combined organization in key roles. The company is planning integration of operations and a rebranding timeline for Texas Partners Bank. Prosperity Bancshares focuses on community and regional banking services, with a footprint...
NasdaqGS:ELVN
NasdaqGS:ELVNPharmaceuticals

Assessing Enliven Therapeutics (ELVN) Valuation After CSO Share Sale And Early Leukemia Trial Progress

Enliven Therapeutics (ELVN) is back in focus after Chief Scientific Officer Joseph P. Lyssikatos sold 20,000 shares, following encouraging early ELVN-001 leukemia trial data and as the company prepares for potential later stage studies. See our latest analysis for Enliven Therapeutics. At a latest share price of $28.17, Enliven’s recent 1 month share price return of 81.27% and 90 day share price return of 48.19% suggest strong momentum. The 1 year total shareholder return of 28.63% points to...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Virgin Galactic Holdings (SPCE) Valuation Check After Prolonged Share Price Weakness

Virgin Galactic’s recent share performance Virgin Galactic Holdings (SPCE) has drawn investor attention after a stretch of weak returns, including a 6% decline over the past day, 11% over the past week, and a 41% decline over the past year. See our latest analysis for Virgin Galactic Holdings. The recent 1 month share price return of an 18.54% decline adds to a much steeper 1 year total shareholder return loss of 41.23%. This suggests momentum has been fading as investors reassess Virgin...
LSE:ENT
LSE:ENTHospitality

UK Stocks Estimated To Be Trading Below Intrinsic Value In February 2026

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index experiencing a downturn influenced by weak trade data from China and declining commodity prices. As these global economic pressures weigh on London markets, investors may find opportunities in stocks that are trading below their intrinsic value, offering potential for long-term growth amidst current uncertainties.
LSE:TBTG
LSE:TBTGConsumer Durables

UK's Top Growth Stocks With High Insider Ownership February 2026

As the United Kingdom's FTSE 100 index experiences fluctuations amid weak trade data from China, investors are keenly observing how global economic conditions impact domestic markets. In this climate, growth companies with high insider ownership can be particularly appealing due to their potential for strong alignment between management and shareholder interests, making them a notable focus in today's market landscape.
LSE:GKP
LSE:GKPOil and Gas

UK Penny Stocks Under £400M Market Cap: 3 Promising Picks

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index slipping due to weak trade data from China and declining commodity prices impacting major companies. Despite these broader market uncertainties, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for investors. These stocks, while sometimes overlooked, can present significant growth potential when supported by strong balance sheets and solid fundamentals.
LSE:0R4W
LSE:0R4WConsumer Finance

Top 3 UK Dividend Stocks With Up To 6.2% Yield

Amidst the recent challenges faced by the UK market, with the FTSE 100 index experiencing declines due to weak trade data from China, investors are increasingly seeking stability and income through dividend stocks. In such uncertain times, companies that offer reliable dividend yields can provide a cushion against market volatility while generating steady cash flow for investors.
TSE:4063
TSE:4063Chemicals

A Look At Shin-Etsu Chemical (TSE:4063) Valuation After Equity Offering And Softer Quarterly Earnings

Shin-Etsu Chemical (TSE:4063) drew investor attention after reporting nine month earnings to December 31, 2025 and moving ahead with a secondary offering of 23,681,700 common shares approved by its board. See our latest analysis for Shin-Etsu Chemical. At a share price of ¥5,127.0, Shin-Etsu Chemical has seen a 5.21% 1 month share price return and a 10.40% 3 month share price return, while total shareholder return over the past year is 13.67%. This suggests momentum has been building despite...
NYSE:CSR
NYSE:CSRResidential REITs

Is Centerspace (CSR) Pricing Reflect Long Term Value After Mixed Recent Share Performance

If you are wondering whether Centerspace's current share price lines up with its underlying value, you are not alone. That is exactly what this article is set up to unpack. Centerspace shares last closed at US$63.83, with returns of 0.0% over 7 days, a 4.7% decline over 30 days, and gains of 10.2% over 1 year, 6.4% over 3 years, and 9.0% over 5 years. These figures hint at changing expectations around both risk and opportunity over different time frames. Recent coverage of Centerspace has...
XTRA:HNR1
XTRA:HNR1Insurance

How Investors May Respond To Hannover Rück (XTRA:HNR1) Appointing a New India CFO

Hannover Rück SE recently appointed Prateek Maheshwari as Chief Financial Officer of its Indian branch, drawing on his nearly 20 years of experience and prior roles within the group, including at Hannover Life Re of Australasia. This leadership change in India comes as investors and analysts increasingly focus on the company’s regional capabilities and financial discipline within key growth markets. We’ll now explore how Maheshwari’s appointment as India CFO shapes Hannover Rück’s investment...
NYSE:ORI
NYSE:ORIInsurance

Old Republic Buyback Reshapes Capital Returns And Earnings Per Share

Old Republic International (NYSE:ORI) has completed a substantial share repurchase program. Since March 2024, the company has retired over 11% of its outstanding shares. The buyback reflects a material capital allocation decision that directly affects existing shareholders. Old Republic International focuses on insurance products and related services, a space that often sees companies return capital through dividends and buybacks. With more than 11% of its share count retired since March...
NYSE:NVR
NYSE:NVRConsumer Durables

NVR Buyback Shrinks Share Base As Earnings And Valuation Come Into Focus

NVR, Inc. (NYSE:NVR) has completed a share repurchase program. The company bought back more than 2% of its outstanding shares. The buyback was executed at a share price near $7,718.38. For investors watching NYSE:NVR, this completed buyback comes alongside a share price of $7,718.38 and multi year returns that range from 49.9% over 3 years to 62.8% over 5 years. Over the past 30 days, the stock shows a 6.0% return, while the 1 year return is slightly negative at 0.2%, giving a mixed picture...
NasdaqGS:OSBC
NasdaqGS:OSBCBanks

Is Old Second Bancorp (OSBC) Pricing Reflect Its Strong Excess Returns Potential

If you are wondering whether Old Second Bancorp at around US$20.24 is offering fair value or a potential bargain, you are in the right place for a clear, valuation focused look at the stock. The share price sits at US$20.24 after returns of 1.8% over the last 7 days, 3.9% over the last 30 days, 3.9% year to date, 10.1% over 1 year and 22.4% over 3 years, with a 5 year return of 89.8%. Recent attention on Old Second Bancorp has been shaped by ongoing sector wide conversations around funding...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

What Does Byrna Technologies’ COO Exit Reveal About Its Leadership Depth And Execution Strategy (BYRN)?

Byrna Technologies Inc. announced that Chief Operating Officer John Brasseur will leave the company on February 17, 2026, to pursue other professional opportunities, with the company stating his departure is not due to disagreements over operations, policies, or practices. For investors, the exit of a key operational leader raises questions about leadership continuity, internal succession plans, and how day-to-day execution might evolve. We will examine how the planned departure of Byrna...